| |
| |
|
| Insider
Information: |
Mohideen Pharis |
| Relationship: |
|
| City: |
Ann Arbor |
| State: |
MI |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
88,592 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$54,378 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
88,592 |
|
|
| Total
Value |
$54,378 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -42.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Tempest Therapeutics, Inc |
TPST |
Chief Medical Officer |
2018-12-07 |
7,440 |
2018-12-07 |
0 |
Premium* |
|
|
DBV Technologies SA |
DBVT |
|
2024-05-24 |
81,152 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DBVT |
DBV Technologies SA |
Chief Medical OfficerOfficer |
• – – |
2021-01-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
15,500 |
|
% |
|
| DBVT |
DBV Technologies SA |
Chief Medical Officer |
• – – |
2021-11-22 |
4 |
A |
$0.00 |
$0 |
D/D |
8,700 |
24,200 |
0 |
- |
|
| DBVT |
DBV Technologies SA |
Chief Medical Officer |
• – – |
2022-07-29 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
34,200 |
0 |
- |
|
| DBVT |
DBV Technologies SA |
Chief Medical Officer |
• – – |
2022-11-21 |
4 |
A |
$0.00 |
$0 |
D/D |
17,500 |
51,700 |
0 |
- |
|
| DBVT |
DBV Technologies SA |
Chief Medical Officer |
• – – |
2022-11-24 |
4 |
S |
$2.88 |
$5,161 |
D/D |
(1,792) |
49,908 |
0 |
% |
|
| DBVT |
DBV Technologies SA |
Chief Medical Officer |
• – – |
2023-05-24 |
4 |
S |
$3.54 |
$1,660 |
D/D |
(469) |
49,439 |
0 |
% |
|
| DBVT |
DBV Technologies SA |
Chief Medical Officer |
• – – |
2023-11-20 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
84,439 |
0 |
- |
|
| DBVT |
DBV Technologies SA |
Chief Medical Officer |
• – – |
2023-11-22 |
4 |
S |
$1.74 |
$3,906 |
D/D |
(2,245) |
82,194 |
0 |
% |
|
| DBVT |
DBV Technologies SA |
Chief Medical Officer |
• – – |
2024-05-22 |
4 |
S |
$1.38 |
$527 |
D/D |
(382) |
81,812 |
0 |
% |
|
| DBVT |
DBV Technologies SA |
Chief Medical Officer |
• – – |
2024-05-24 |
4 |
S |
$1.36 |
$898 |
D/D |
(660) |
81,152 |
0 |
% |
|
| TPST |
Tempest Therapeutics, Inc |
Chief Medical Officer |
• – – |
2018-12-07 |
4 |
A |
$0.00 |
$0 |
D/D |
7,440 |
7,440 |
0 |
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
